Tokyo, Jan. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060148) titled 'Research on the characteristics and outcomes of pancreatic diseases' on Jan. 1.
Study Type:
Observational
Primary Sponsor:
Institute - The University of Tokyo
Condition:
Condition - Pancreatic diseases (including fatty pancreas, pancreatic cysts, asymptomatic morphological changes of the pancreas, and asymptomatic pancreatic enzyme elevation)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To examine the characteristics of and outcomes of pancreatic diseases
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Individuals who undergo a health checkup during the study period
Key exclusion criteria - Participants with missing data on the main exposure variable of a given analysis
Target Size - 100000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 11 Month 20 Day
Date of IRB - 2025 Year 12 Month 18 Day
Anticipated trial start date - 2026 Year 01 Month 01 Day
Last follow-up date - 2030 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067995
Disclaimer: Curated by HT Syndication.
